[The influence of noradrenaline on controlled reversion of visceral xanthomatosis].
D000311:Adrenal Glands / Q000473:pathology; D000818:Animals; D001012:Aorta, Abdominal / Q000473:pathology; D001013:Aorta, Thoracic / Q000473:pathology; D002784:Cholesterol; D008168:Lung / Q000473:pathology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D011817:Rabbits; D012077:Renal Artery / Q000473:pathology; D013154:Spleen / Q000473:pathology; D013501:Surface-Active Agents; D014973:Xanthomatosis / Q000139:chemically induced* / Q000473:pathology
D013501:Surface-Active Agents; D002784:Cholesterol; D009638:Norepinephrine
L'influsso della noradrenalina sulla reversione controllata della xantomatosi viscrale.